share_log

Cautious Investors Not Rewarding Guangdong Guanghua Sci-Tech Co., Ltd.'s (SZSE:002741) Performance Completely

慎重な投資家は、広東広華科技有限公司(SZSE:002741)の業績を完全に評価していない

Simply Wall St ·  06/07 02:06

With a median price-to-sales (or "P/S") ratio of close to 1.9x in the Chemicals industry in China, you could be forgiven for feeling indifferent about Guangdong Guanghua Sci-Tech Co., Ltd.'s (SZSE:002741) P/S ratio of 1.5x. While this might not raise any eyebrows, if the P/S ratio is not justified investors could be missing out on a potential opportunity or ignoring looming disappointment.

ps-multiple-vs-industry
SZSE:002741 Price to Sales Ratio vs Industry June 7th 2024

How Has Guangdong Guanghua Sci-Tech Performed Recently?

While the industry has experienced revenue growth lately, Guangdong Guanghua Sci-Tech's revenue has gone into reverse gear, which is not great. Perhaps the market is expecting its poor revenue performance to improve, keeping the P/S from dropping. If not, then existing shareholders may be a little nervous about the viability of the share price.

If you'd like to see what analysts are forecasting going forward, you should check out our free report on Guangdong Guanghua Sci-Tech.

Do Revenue Forecasts Match The P/S Ratio?

There's an inherent assumption that a company should be matching the industry for P/S ratios like Guangdong Guanghua Sci-Tech's to be considered reasonable.

Taking a look back first, the company's revenue growth last year wasn't something to get excited about as it posted a disappointing decline of 20%. That put a dampener on the good run it was having over the longer-term as its three-year revenue growth is still a noteworthy 14% in total. Although it's been a bumpy ride, it's still fair to say the revenue growth recently has been mostly respectable for the company.

Looking ahead now, revenue is anticipated to climb by 56% during the coming year according to the two analysts following the company. With the industry only predicted to deliver 23%, the company is positioned for a stronger revenue result.

With this in consideration, we find it intriguing that Guangdong Guanghua Sci-Tech's P/S is closely matching its industry peers. Apparently some shareholders are skeptical of the forecasts and have been accepting lower selling prices.

What Does Guangdong Guanghua Sci-Tech's P/S Mean For Investors?

Generally, our preference is to limit the use of the price-to-sales ratio to establishing what the market thinks about the overall health of a company.

Despite enticing revenue growth figures that outpace the industry, Guangdong Guanghua Sci-Tech's P/S isn't quite what we'd expect. There could be some risks that the market is pricing in, which is preventing the P/S ratio from matching the positive outlook. This uncertainty seems to be reflected in the share price which, while stable, could be higher given the revenue forecasts.

There are also other vital risk factors to consider before investing and we've discovered 1 warning sign for Guangdong Guanghua Sci-Tech that you should be aware of.

Of course, profitable companies with a history of great earnings growth are generally safer bets. So you may wish to see this free collection of other companies that have reasonable P/E ratios and have grown earnings strongly.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする